Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Endocrinology
•
Bone and Calcium Disorders
Is the FRAX score reliable in assessing fracture risk for patients with history of prior bisphosphonate use?
Related Questions
How do you approach vitamin D supplementation in patients with chronic kidney disease, given the findings that vitamin D2 supplementation may lead to decreased conversion of 25-hydroxyvitamin D3 to 1,25-dihydroxyvitamin D3?
Are there certain patients with primary hyperparathyroidism for whom you would consider percutaneous ablation of a parathyroid adenoma over surgical parathyroidectomy?
Which method provides a more accurate assessment of hypercalciuria: 24-hour urinary calcium excretion or the spot urine calcium-to-creatinine ratio?
Is it reasonable to tell patients that Evenity lowers fracture risk by about 70%, while Prolia reduces it by around 50%?
At what age and how often do you screen for osteoporosis in non-ambulatory (e.g. developmentally disabled) young adults without other risk factors?
How long after a successful parathyroid surgery would you reassess bone density in a patient with severe osteoporosis ?
In post-bariatric surgery patients presenting with secondary hyperparathyroidism, what is the optimal approach to assess calcium supplementation adequacy?
How do you decide when to treat hypocalcemia in hospitalized patients?
Does cinacalcet reduce hypercalciuria in primary hyperparathyroidism?
When stopping denosumab and transitioning to PO bisphosphonate, do you wait for 6 months after the last denosumab injection to start PO bisphosphonate?
